Enclomiphene in Corona, CA — Testosterone Support That Preserves Fertility
What enclomiphene is, honestly
Enclomiphene is a selective estrogen receptor modulator. It blocks estrogen signaling at the pituitary, which prompts the body to increase its own LH and FSH, which in turn signals the testes to produce more testosterone. The distinction that matters: it raises your own testosterone production rather than replacing it from outside.
That difference has one significant clinical consequence. Testosterone replacement therapy suppresses the signals that drive sperm production, and for many men it reduces fertility while they are on it. Enclomiphene works by amplifying those same signals, so it does not carry that effect.
At Slender Me Medical in Corona, enclomiphene is prescribed and monitored by a licensed nurse practitioner, in office or by telehealth.
Book a consultation · Start online
Its regulatory status, stated plainly
Enclomiphene has never been approved by the FDA as a standalone medication. It was developed as Androxal, and three applications between 2009 and 2015 were all met with Complete Response Letters, the most recent citing insufficient cardiovascular safety data.
It is available in the United States only through compounding pharmacies operating under Sections 503A or 503B, with a valid prescription. Retail pharmacies cannot dispense it because no approved commercial product exists.
In 2022 the FDA’s Pharmacy Compounding Advisory Committee voted against adding enclomiphene to the final 503A Bulks List, citing limited clinical efficacy evidence. As of May 2026 the FDA still lists it as under evaluation, which means compounding continues to be permitted while that review is open. This is an unsettled regulatory position, not a settled approval, and it could change.
We tell you this before you start rather than after. If you would rather be on a medication with a finished FDA label and decades of post-market data, testosterone replacement is that medication, and it is a legitimate choice.
What the evidence shows
The trial data is real but limited. In pooled results from the Androxal program, a 25 mg daily dose brought testosterone above 300 ng/dL in roughly 82% of participants. A separate trial of 265 men found enclomiphene raised testosterone by about 147 ng/dL more than placebo. Trials consistently showed LH and FSH rising alongside testosterone, which is the mechanism working as expected, and sperm counts were maintained.
What the evidence does not show: long-term outcomes. The trials were relatively small and ran for months rather than years. They were not large enough to detect rare serious adverse events, and no study has followed enclomiphene users over a decade the way testosterone therapy has been followed. Reported side effects in trials were mostly mild and uncommon, but “uncommon in a small trial” is a weaker statement than it sounds.
Who it suits
Enclomiphene is generally considered for men with secondary hypogonadism — low testosterone caused by inadequate pituitary signaling rather than testicular failure. That distinction is not cosmetic. If your testes are not capable of responding, amplifying the signal accomplishes nothing, and testosterone replacement is the appropriate treatment.
The men who benefit most are typically:
- Younger men who want to preserve fertility, now or later
- Men whose bloodwork shows low testosterone with low or normal LH and FSH
- Men who would prefer to avoid weekly injections or daily gels
- Men currently on TRT who want to transition off while maintaining testosterone levels
Determining which category you fall into requires bloodwork, not a questionnaire. Total and free testosterone, LH, FSH, estradiol, prolactin, and a CBC and metabolic panel at minimum.
Who it does not suit
Men with primary hypogonadism. If the testes cannot respond, this will not work.
Men with a history of blood clots or significant cardiovascular disease. The FDA’s stated reason for not approving enclomiphene was inadequate cardiovascular safety data. That does not mean it is unsafe, but it does mean the question was never fully answered, and men with existing cardiovascular risk deserve to weigh that.
Men with untreated sleep apnea, elevated hematocrit, or an active prostate concern. These need addressing before any testosterone-raising therapy.
Anyone unwilling to do follow-up labs. This is not a prescription to fill and forget. Testosterone, estradiol, and hematocrit need rechecking.
Women. Enclomiphene is not prescribed to women at this practice.
Enclomiphene compared to testosterone replacement
Neither is better. They do different things.
Testosterone replacement is FDA-approved, extensively studied, reliably effective, and available as a finished product with standardized manufacturing. It also suppresses natural production and typically reduces fertility while in use. Coming off it often means a difficult recovery period.
Enclomiphene preserves the natural signaling axis and fertility, involves a daily tablet rather than injections, and does not shut down your own production. It is unapproved, compounded, less studied, generally produces more modest testosterone increases than direct replacement, and depends on your pituitary and testes still being capable of responding.
For a man in his thirties who wants children, that trade-off usually favors enclomiphene. For a man in his sixties with primary hypogonadism and no fertility concerns, it usually favors testosterone. Most decisions sit somewhere between, which is what the consultation is for.
Compounded medication and what it means
Compounded enclomiphene is prepared by a licensed pharmacy from bulk pharmaceutical-grade material. It is the same molecule studied in the trials. What differs is the manufacturing oversight: a compounded preparation has not gone through the bioequivalence testing, stability studies, and standardized labeling that an approved product requires.
Practically, that means the pharmacy matters. Isomeric purity in particular can vary between sources, and enclomiphene is specifically the trans-isomer of clomiphene — the other isomer has a much longer half-life and different effects. We work with pharmacies that provide certificates of analysis, and you are welcome to ask which pharmacy fills your prescription and why.
What treatment involves
Baseline labs. Drawn in the morning when testosterone is highest, and confirmed on a second draw before starting, because a single low reading is not a diagnosis.
Consultation. Reviewing your labs, symptoms, medical history, fertility plans, and cardiovascular risk. This is where we determine whether enclomiphene, testosterone, or neither is right.
Starting. Typical dosing is 12.5 mg to 25 mg daily. There is no FDA-approved dosing guidance, so this comes from the trial protocols and clinical experience.
Recheck at six to eight weeks. Testosterone, estradiol, LH, FSH, and hematocrit. Dose is adjusted from there.
Ongoing monitoring at regular intervals for as long as you are on treatment.
Insurance rarely covers compounded enclomiphene. Expect to pay out of pocket, and ask us for current pricing at your consultation.
Common questions
Is enclomiphene legal?
Yes. It is not a controlled substance, and it is legally prescribed and dispensed through compounding pharmacies. It is not FDA-approved, which is a different question from legality.
Will it affect my fertility?
Unlike testosterone replacement, enclomiphene raises LH and FSH rather than suppressing them, and trials showed sperm counts maintained. It is the main reason men choose it.
How long until I notice anything?
Testosterone typically rises within weeks. Symptom changes — energy, mood, libido — usually take longer and vary considerably.
Can I switch from TRT to enclomiphene?
Often, but it requires a planned transition and monitoring. Do not stop testosterone abruptly on your own.
Do I take it forever?
That depends on why your testosterone is low. Some men use it for a defined period, others continue long term. It is a reasonable thing to revisit at each follow-up.
Why isn’t it FDA-approved?
Three applications were submitted and none succeeded, with the most recent rejection citing insufficient cardiovascular safety data. The developer was subsequently acquired and development did not resume.
Book
Slender Me Medical
2083 Compton Avenue, Suite 101, Corona, CA 92881
(951) 898-8515
Open six days a week including Saturdays
Book a consultation · Start online
This page is for education and does not replace a medical evaluation. Enclomiphene is not approved by the FDA and is available only as a compounded preparation with a valid prescription. It is prescribed here for secondary hypogonadism following laboratory evaluation. Individual results vary.